Clinical Trial

KERMIT: Sweat Patch for Early Kidney Disease Detection

Study acronym: KERMIT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 2, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Chronic kidney disease (CKD) affects over 10% of the global population, leading to significant morbidity, mortality, and economic burden. Early detection is crucial for preventing disease progression and complications; however, awareness and diagnosis of CKD remain alarmingly low. Current methods rely on blood or urine analysis, which are invasive and require specialized facilities. The KERMIT patch aims to address this gap by providing a wearable lab-on-a-chip device capable of measuring key biomarkers from sweat non-invasively. This innovation has the potential to revolutionize CKD diagnosis, particularly in remote or underserved areas. The KERMIT patch integrates functional printed biosensors, a high-frequency electrochemical microchip, and a sustainable microfluidic system. Sensors are fabricated using carbon inks and 2D materials, enabling immunodetection and non-enzymatic sensing of creatinine, urea, and cystatin C. Preliminary tests evaluated detection limits, skin compatibility, and carbon footprint.
Trial Details
NCT Number NCT07047664
Lead Sponsor University of Ioannina
Conditions Chronic Kidney Disease (CKD)
Enrollment 52 participants
Start Date 2025-07-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-07-02